Machine Learning for Real-World Evidence Analysis of COVID-19 Pharmacotherapy

no code implementations • 19 Jul 2021 • Aurelia Bustos, Patricio Mas_Serrano, Mari L. Boquera, Jose M. Salinas

2390 admissions from 2 additional health departments were reserved as an independent test to analyze retrospectively the survival benefits of therapies in the population selected by the TE-ML models using cox-proportional hazard models.

BIG-bench Machine Learning Decision Making